Taiwan: ad hoc seminars for Hilterapia®

29 January 2018 - Trade fairs & Congresses -

The objectives of the seminars organised by ASAlaser, in collaboration with the Taiwanese partner Gaia Genomics, in Taichung (13 January at the Taichung Rehabilitation Association) and in Taipei (14 January, local partner’s facilities), aim to allow a correct knowledge of Hilterapia®, understanding its uses and therapeutic benefits. Implemented in collaboration with industry associations and focusing on rehabilitation and physiotherapy physicians and professionals, the meetings not only provided a technical-scientific overview of the therapy, allowing an understanding of its specific nature in relation to others on the market, but also enabled verifying the practical aspect thanks to the cases reported by local professionals. "In Taipei - explains Giacomo Granozio, ASAlaser’s Area Manager - we were able to rely on the contribution by a physiotherapist from the National Cheng Kung University Hospital with whom our Clinical Department is carrying out some "on site" research. His speech was divided into two phases which allowed participants to tangibly understand the uses and effectiveness of Hilterapia®: in addition to sharing his personal clinical experience and to reporting the first results of the research being carried out, the physiotherapist also showed some successfully treated recent cases, followed by a stimulating discussion and comparison. The technical/scientific approach together with the practical field experience proved to be successful both for correctly conveying the therapy and for establishing relationships based on trust".

You might also be interested in ...

See all articles

Medica 2022 - ASA staff
News - 24/11/2022
For the 2022 edition of Medica, ASA steps on the throttle by adding to the institutional stand a satellite exhibition space in pavilion 4, focused on physiotherapy.
ASA and Asian Star @ Kimes Busan 2022
News - 10/11/2022
After three years of forced stop due to the pandemic and the related restrictions, ASA’s leading therapies - Hilterapia® and MLS® Laser Therapy - are once again protagonists during the Kimes Busan...
Training MiS nel Dolore Neuropatico - Abruzzo 2022
News - 10/11/2022
Led by Ms Mezzalira, participants received several indications for best exploiting the features of MiS in the field of Neuropathic Pain, and held a discussion on important topics of interest, such as...
Press - 24/01/2023
Its effectiveness in reducing pain, the unique features on the market and its total safety are some of the aspects of Hilterapia® outlined during a report by TGCOM24
Press - 09/01/2023
Can wounds be healed in space? The answer is provided by the experiment “Suture in Space”, in which ASA played a leading role.
Press - 23/12/2022
ASAcampus is once again at the frontline for the second step of the experiment “Suture in Space”, which aims to study the repair mechanisms of tissues and the healing of wounds in the absence of...